|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||1.2500 - 1.3500|
|52 Week Range||1.0000 - 6.0700|
|Beta (5Y Monthly)||1.75|
|PE Ratio (TTM)||N/A|
|Earnings Date||Mar 14, 2023 - Mar 20, 2023|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||3.32|
TerrAscend Corp. ("TerrAscend") (CSE: TER) (OTCQX: TRSSF), a leading North American cannabis operator, today announced the closing of its previously announced acquisition of Allegany Medical Marijuana Dispensary ("AMMD"), a medical dispensary in Cumberland, Maryland. Under the terms of the agreement (the "Transaction"), TerrAscend has acquired a 100% equity interest in AMMD for total consideration of US$10 million in cash, in addition to entering into a long-term lease with the option to purchas
TerrAscend Corp. ("TerrAscend") (CSE: TER) (OTCQX: TRSSF), a leading North American cannabis operator, today announced a multi-year agreement (the "Agreement") with Wana Brands ("Wana"), the leading edibles manufacturer in North America, to introduce Wana's products at The Apothecarium retail stores and additional third-party retailers in New Jersey. The agreement will also transfer to TerrAscend, the manufacturing and sales of Wana's existing portfolio of products in Maryland.
Curaleaf CEO Matt Darin and TerrAscend Executive Chairman Jason Wild sit down with Yahoo Finance to break down the cannabis industry's outlook for federal legalization in the U.S. and the growth seen despite Congress' stalling of the SAFE Banking Act.